These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2759713)

  • 1. Immunoglobulin E response to pertussis toxin in whooping cough and after immunization with a whole-cell and an acellular pertussis vaccine.
    Hedenskog S; Björkstén B; Blennow M; Granström G; Granström M
    Int Arch Allergy Appl Immunol; 1989; 89(2-3):156-61. PubMed ID: 2759713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoglobulin E and G responses to pertussis toxin in children immunised with adsorbed and non-adsorbed whole cell pertussis vaccines.
    Duchén K; Granström M; Hedenskog S; Blennow M; Björkstén B
    Vaccine; 1997 Oct; 15(14):1558-61. PubMed ID: 9330468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin E and G responses to pertussis toxin after booster immunization in relation to atopy, local reactions and aluminium content of the vaccines.
    Odelram H; Granström M; Hedenskog S; Duchén K; Björkstén B
    Pediatr Allergy Immunol; 1994 May; 5(2):118-23. PubMed ID: 8087191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis IgE and atopic disease.
    Nilsson L; Grüber C; Granström M; Björkstén B; Kjellman NI
    Allergy; 1998 Dec; 53(12):1195-201. PubMed ID: 9930597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of circulating antibodies directed to pertussis toxin and of agglutinogens in children vaccinated with either the whole cell or component pertussis vaccine in France, Japan and Senegal.
    Relyveld E; Oato NH; Guérin N; Coursaget P; Huet M; Gupta RK
    Vaccine; 1991 Nov; 9(11):843-50. PubMed ID: 1759508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization.
    Edelman K; Malmström K; He Q; Savolainen J; Terho EO; Mertsola J
    Eur J Pediatr; 1999 Dec; 158(12):989-94. PubMed ID: 10592076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
    Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
    J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.
    Ryan EJ; Nilsson L; Kjellman N; Gothefors L; Mills KH
    Clin Exp Immunol; 2000 Aug; 121(2):193-200. PubMed ID: 10931131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age.
    Huang LM; Lee CY; Lin TY; Chen JM; Lee PI; Hsu CY
    Vaccine; 1996 Jun; 14(9):916-22. PubMed ID: 8843635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Humoral response to the injection of acellular Pertussis vaccine].
    Zakharova NS; Remova TN; Britsina MV; Shmeleva EI; Mertsalova NU; Zaĭtsev EM; Ozeretskovskaia MN; Bazhanova IG; Ermolova EV
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (6):40-4. PubMed ID: 11881494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
    Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
    J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
    Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD
    Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
    Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
    Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG; Ashworth LA; Miller E; Lambert HP
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines.
    Edwards KM; Decker MD; Bradley RB; Taylor JC; Hager CC
    Pediatr Infect Dis J; 1991 Apr; 10(4):315-8. PubMed ID: 2062628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a three-component acellular pertussis vaccine administered at birth.
    Belloni C; De Silvestri A; Tinelli C; Avanzini MA; Marconi M; Strano F; Rondini G; Chirico G
    Pediatrics; 2003 May; 111(5 Pt 1):1042-5. PubMed ID: 12728086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ten year follow-up after immunization with a two component acellular pertussis vaccine.
    Tindberg Y; Blennow M; Granström M
    Pediatr Infect Dis J; 1999 Apr; 18(4):361-5. PubMed ID: 10223691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD; Gornbein J; Heininger U; Stehr K
    Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
    Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
    Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.